SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
Li D et al. Diabetes Obes Metab 2018; Advance online publication. doi: 10.1111/dom.13294
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.